SCHEMBL291242

SCHEMBL291242

CC(C)C1CCC(C)(C(N)=O)CC1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 2/20 0.39
ALOX5 P09917 1/20 0.35
TDP1 Q9NUW8 1/20 0.32
EPHX1 P07099 3/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
PKM P14618 1/20 0.31
RET P07949 1/20 0.31
MAPK14 Q16539 1/20 0.31
CAMK1D Q8IU85 1/20 0.31
FFAR3 O14843 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2701836 0.81 FFAR3 (0.54) OPRL1SLC1A2SLC1A1FFAR3L3MBTL1
SCHEMBL663384 0.81 FFAR3 (0.54) OPRL1SLC1A2SLC1A1FFAR3L3MBTL1
SCHEMBL5277555 0.79 FFAR3 (0.31) OPRL1FFAR3
Fluoride SCHEMBL10012083 0.79 FFAR3 (0.52) OPRL1SLC1A2SLC1A1FFAR3L3MBTL1
SCHEMBL10012078 0.79 FFAR3 (0.31) OPRL1FFAR3
SCHEMBL1468235 0.76 FFAR3 (0.33) OPRL1FFAR3
SCHEMBL2700864 0.76 FFAR3 (0.33) OPRL1FFAR3
SCHEMBL2701515 0.76 FFAR3 (0.33) OPRL1FFAR3
SCHEMBL305654 0.76 TRPA1 (0.35) OPRL1ALOX5EPHX1FFAR3L3MBTL1
SCHEMBL305655 0.76 TRPA1 (0.35) OPRL1ALOX5EPHX1FFAR3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930456-A Method for preparing N-ethyl-L-menthyl formamide by continuous flow technology 安徽科芯微流化工科技有限公司 2025-05-06 CN claimed
CN-119632894-A Preparation method of gum-protecting tooth-fixing toothpaste 杭州博济堂健康咨询管理有限公司 2025-03-18 CN claimed
CN-117243884-B Composition containing fermentation active substance for improving skin barrier, preparation method and application thereof 广州瑞誉化工科技有限公司 2024-04-05 CN claimed
CN-117479843-A Composition for enhancing cooling effect 弗门尼舍公司 2024-01-30 CN claimed
CN-117338631-A Skin care lotion prepared based on bidirectional indissolvable substance microemulsifying technology and preparation method thereof 贵州九立德生物制药有限公司 2024-01-05 CN claimed
CN-117243884-A Composition containing fermentation active substance for improving skin barrier, preparation method and application thereof 广州瑞誉化工科技有限公司 2023-12-19 CN claimed
WO-2023063269-A1 NONAQUEOUS COMPOSITION FOR ORAL CAVITY ライオン株式会社 2023-04-20 WO claimed
EP-2346475-B2 PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION PROCTER & GAMBLE (US) 2023-04-19 EP claimed
CN-113081900-B Gargle and preparation method and application thereof 河北科技大学 2023-03-31 CN claimed
CN-113499286-B Cleaning and nursing composition, cleaning and nursing liquid and preparation method thereof 福建省千喜健康科技有限公司 2023-02-24 CN claimed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 EP claimed
EP-2167024-A2 COOLING COMPOUNDS Givaudan SA (CH) 2010-03-31 EP claimed
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products THE PROCTER & GAMBLE COMPANY 2010-03-25 US claimed
WO-2010019730-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2010-02-18 WO claimed
WO-2009105740-A2 ABSORBENT ARTICLE COMPRISING LOTION COMPOSITION COMPRISING A COOLING AGENT THE PROCTER & GAMBLE COMPANY (US) 2009-08-27 WO claimed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO claimed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO claimed
WO-2008151460-A2 COOLING COMPOUNDS GIVAUDAN SA (CH) 2008-12-18 WO claimed
WO-2008049651-A1 PERFORMANCE-ENHANCED COSMETIC COMPOSITIONS WITH PURINE AND/OR PURINE DERIVATIVES HENKEL AG & CO. KGAA (DE) 2008-05-02 WO claimed
EP-1880705-A2 Brightening and/or colouring composition with improved product sensation HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-01-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products NISCH, TRPM4, TRPM8 OPRL1 347/4885ALOX5 715/4885TDP1 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.